Lucine: Funding, Investors & Team (Oct 2026)
Lucine has the ambition to transform and improve patient’s health. Their main therapeutic area is pain. The product, a digital therapeutic is able to relieve patient’s pain in 5 minutes through active substances allowing an analgesic neurostimulation. Customized, their solution is adapted to each patient thanks to an instantaneous measurement and analysis of the pain by facial, vocal and postural recognition.
Lucine has raised $5.5M across 1 funding round on record, the most recent an undisclosed round of $5.5M announced in Nov 2020.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Lucine Company Profile and Key Stats
Latest funding round on record: Nov 2020.
Lucine Funding Rounds
Lucine Founders and Leadership Team
Contact details for the Lucine team: 1 of 1 has an email address on file.
Start 14-day free trial →Lucine Funding Compared to Other Biotechnology Startups
Lucine's latest round of $5.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Lucine in Biotechnology and Bordeaux
Companies Similar to Lucine
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
Lucine Funding FAQs
What does Lucine do?
Lucine has the ambition to transform and improve patient’s health. Their main therapeutic area is pain. The product, a digital therapeutic is able to relieve patient’s pain in 5 minutes through active substances allowing an analgesic neurostimulation. Customized, their solution is adapted to each patient thanks to an instantaneous measurement and analysis of the pain by facial, vocal and postural recognition.
How much funding has Lucine raised?
Lucine has raised $5.5M across 1 round on record. The most recent is an undisclosed round of $5.5M announced in Nov 2020.
When did Lucine last raise funding?
Lucine's most recent funding round on record is an undisclosed round of $5.5M, announced in Nov 2020.
Who is the CEO of Lucine?
Aymeric Esperance is listed as CEO at Lucine.
Where is Lucine headquartered?
Lucine is based in Bordeaux, Aquitaine, France.
How many employees does Lucine have?
Lucine is in the 11-50 employee band.
How does Lucine's funding compare to other Biotechnology startups?
Lucine's latest round of $5.5M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Lucine Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lucine is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.